Monday, July 27, 2020

How COVID-19 devastated African Safari industry

This article is by

Share this article

Article Contributor(s)

Charvi Trivedi

Article Title

How COVID-19 devastated African Safari industry

Publisher

Global Views 360

Publication Date

July 27, 2020

URL

African Safari

African Safari | Source: Sneha via Unsplash

With COVID-19 wrecking the economies of superpowers like the US and China, Africa is no exception. The continent of Africa is bestowed with rich biodiversity which attracts millions of tourists every year. But due to the pandemic, the safari industry of Africa is in a freefall.

The countries which are visited more often by the international tourists for their remarkable safari experiences include Botswana, Kenya, Namibia, Rwanda, South Africa, Tanzania, Uganda and Zambia. These contribute more than 12 billion US dollars to the economy, according to the United Nations World Tourism Organization (UNWTO).

The tourism industry is one of the most impacted economic sectors due to lockdowns being imposed all over the world. The magnitude of loss came into light when Safaribookings.com, a website for booking safari tours in Africa, ran its fourth monthly survey. The bookings this year declined by a massive 75%. “We don’t have bookings, and we don’t have money to pay salaries for staff, office rental etc. Things are really bad” says a Kenyan safari vehicle operator. Thousands of the people depending on services related to industry lost the livelihood due to this downturn..

Khimbini Hlongwane, the proprietor of a small tour business in Kruger National Park of South Africa, is devastated as he had invested all his savings to purchase a new minibus for his visitors. “It hasn’t moved since the day we bought it,” he says.  Leon Plutsick, who owns a lodge in Manyeleti private game reserve adjacent to the Kruger National Park says that he is barely surviving on the remaining meagre reserves. What used to be a lodge packed with tourists, is now replaced by Baboons. A tour guide and father of four, Sipho Nkosi, who earns a decent amount of 550 rand per tour, finds himself and his family in troubled waters. “We’d saved some money. But it's running out, so we’ll start starving” he says.

Not only the local communities but also the prolific wildlife of Africa is bearing the brunt of the pandemic. Tourist funds play a key role in conservation projects. Jackson Looseyia, a conservationist and lodge owner at Maasai Mara says, “In conservation terms, it is a crisis. We have no money coming in whatsoever, and the future is so bleak”.

Many of the families dependent on ecotourism see no option but to turn towards poaching as a means of survival. This further poses a threat to the species. Dickson Kaelo, CEO of Kenya Wildlife Conservancies Association says, “Due to the high rates of unemployment, commercial bushmeat has become rampant in some areas. Recently there were even cases of giraffes killed for commercial purposes”. At least six black rhinos, who might face extinction soon, were killed by poachers in Okavango Delta, Botswana, in the month of March. Efforts are being taken to evacuate the remaining rhinos and shift them to safer places.

The Tourism Business Council of South Africa is urging the government to reopen the national parks and sanctuaries for the public, latest by September. However, the South African government states that the tourism industry is not likely to reopen before 2021.

Kenya, Namibia and Rwanda are not open for tourists. Zambia is permitting tourists but with an obligatory two-week quarantine. Tanzania has imposed no such requirements. However, tourists will think twice before going on any international trips as we have not yet won the fight against coronavirus.

All this has left the people associated with the ecotourism sector in Africa in a dark tunnel with seemingly no end at the moment.

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 5:14 PM

Asian countries & the race for COVID-19 Vaccine

Our relationship with the new strain of coronavirus is almost 8 months strong now. Countries like the US, Russia, UK, China, India, and many more have already set their brainy scientists in the task of developing a vaccine, turning it into a race which desperately needs a winner, since no one wants this deadly relationship to endure. Several attempts have proved to be successful, especially in countries like Russia, USA, India, and China.

China was the first to start scouring for a vaccine the day WHO declared that the new strain of SARS-CoV, originating in Wuhan-China, has resulted in a pandemic. It is a fierce competitor, especially to the US, as almost 8 of the 24 promising vaccines approved for clinical trials are from China. It used the technology of ‘inactivated vaccine’ which basically means killing the actual virus and using that to create a vaccine. This method is quite useful in treating measles and influenza, thus, increasing the chances of success in the case of COVID-19 as well.

“It’s a tried and true strategy”, Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said  about the inactivated vaccine. One potential vaccine from China-based Sinopharm is already in the phase 3 of trials whereas Sinovac will enter the third phase this month. Moreover, China has permitted Sinovac and Sinopharm to dilute phase 1 and 2 of vaccine trials on humans to hasten the process.

The head of the Chinese Center for Disease Control and Prevention, Gao Fu, had also been injected with a potential vaccine on July 28, 2020. “I’m going to reveal something undercover: I am injected with one of the vaccines'' Gao Fu said in a webinar hosted by Alibaba Health, an arm of the Chinese e-commerce giant, and Cell Press, an American publisher of scientific journals. However, he did not reveal any more details about how and when exactly he administered himself with the vaccine and ‘hopes’ that the vaccine works.

Vladimir Putin, President of Russia | Source: Wikimedia

Elsewhere in Russia, on August 11, 2020, President Vladimir Putin proudly announced that Russia was the first country to grant regulatory approval to their vaccine after carrying out human trials for less than 2 months by the Gamalei Institute in Moscow. Regulatory approval permits vaccination of the masses. Although it has not undergone phase 3 of trials, Russia expects to initiate mass production of the vaccine by the end of this year. Kirill Dmitriev, head of Russia's sovereign wealth fund states that the vaccine will be called ‘Sputnik V’, named after Sputnik 1, the first satellite launched by Soveit Union which was a euphoric moment for Russia. More recently, China and Russia have joined hands in proceeding with the clinical trials of their vaccines.

These two instances seem to bring a new hope for the future, yet raise alarms and invite scepticism from the experts in the field of public health. One major concern is that without prolonged trials, vaccines should not be authorized for public use. Anthony Fauci, an infectious disease expert based in the US said “I do hope the Chinese and the Russians are actually testing the vaccines before they are administering the vaccine to anyone. Because claims of having a vaccine ready to distribute before you do testing is problematic at the very least”. Hence, some people are still in doubt regarding the safety of the product. Putin, however, rubbished such concerns and said "I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks".

An Indian biotechnological company, Bharat Biotech developed ‘Covaxin’ in collaboration with Indian Council for Medical Research (ICMR), using the mechanism of inactivated vaccine. It was successful in getting approval for human trials which were scheduled to begin in July, 2020. Initial reports stated that it would be ready for mass use by August 15, 2020, which also marked the 73rd Independence Day of India. However, Bharat biotech was clear in letting the public know that phase 1 of the trials are still on-going. ICMR cleared the confusion by stating that it would prepare the results of the phase 1 trials by August 15, 2020, not the actual vaccine for use. Phase 2 of the trials are awaited in September, 2020.

So far, the results of phase 1 trials have been positive as no serious side-effects are observed in the vaccine candidates. “The vaccine has been safe. No adverse effect has been reported. Even the point of injection pain, which is normal in vaccines, has been very mild” said Dr Kushwaha of Prakhar Hospital.

Meanwhile, the South Korean government stated on August 21, 2020, that it will secure adequate vaccine supply to its citizens by cooperating with international bodies and promoting local drug development. Three South Korean companies have started the process of making a vaccine and all are in the clinical trial phase. Bill Gates asserts that the South Korean pharmaceutical company, SK Bioscience, will have around 200 million vaccine doses ready by June 2021.

Japan is jointly collaborating with the UK, France and other European countries to establish a $20 billion fund to buy coronavirus vaccines, with Japan pledging a contribution of $800 million. It’s vaccine program aims to focus on giving primary attention to its medical workers and the elderly people of the country when the first doses of the vaccine are made. The state-funded vaccination program is believed to be officially adopted by Japan in September this year with negotiations with the UK and US based drug makers already in place.

With the race to bring COVID-19 vaccine seemingly coming to a close and it will hopefully be ready by the end of 2020 or early 2021. Till then, the entire world is watching this race with bated breath.

Read More